Cancer cells often have [mutations](#) in genes that regulate the G2 phase checkpoints. For instance, mutations in the [TP53](#) gene, which encodes the p53 protein, can lead to the loss of G2 checkpoint control. This allows cancer cells to bypass the repair mechanisms and continue proliferating despite having genetic abnormalities.
